Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site by Mohammad T. Mazhab-Jafari and others Created 2026-10-20 Updated 2026-10-31
View more
Proceedings of the National Academy of Sciences 112, 6625–6630 (2015). doi.org/10.1073/pnas.1419895112
Read the full article